TRT and Mood: Do Testosterone Level Swings Affect Mental Well-Being?

This is an entirely different topic from the question of whether testosterone therapy treats clinical depression in men with diagnosed hypogonadism — we've devoted a separate article to that question, because the evidence for it is more modest and ambiguous than some marketing claims suggest. Here, we focus exclusively on the mechanism of mood fluctuations tied to the dosing rhythm, not on treating mood disorders as such.

After an intramuscular or subcutaneous injection of an ester-based testosterone (such as enanthate or cypionate), blood hormone levels rise quickly, usually reaching a peak within 24 to 72 hours, often well above the physiological range, and then gradually decline over the following one to two weeks until the next injection. With a dosing schedule of every two to three weeks in a single large dose, this gap between the peak concentration and the lowest point before the next injection (the trough) can be substantial — and it's precisely this amplitude and rate of change, not the average testosterone level across the cycle, that appears to matter most for subjectively reported swings in mood, energy, and libido.

During the peak phase, some men report elevated mood, more energy, and more confidence, sometimes alongside irritability or lower tolerance for stress. During the declining phase, especially in the days right before the next injection, fatigue, reduced motivation, low mood, and sometimes marked irritability are reported — a pattern some patients describe as their own, predictable „cycle” correlated with their injection calendar.

The mechanism for easing this effect is mathematically simple: the more frequently a smaller dose is given, the smaller the gap between peak and trough concentration within the dosing cycle, because the next injection „tops up” the level before it has a chance to drop too low. This is one of the main clinical arguments for moving from dosing every two to three weeks to weekly or more frequent dosing, even at the same total monthly dose — as well as for delivery forms that inherently give a more stable concentration profile, such as transdermal gels, patches, or subcutaneous implants.

It's worth noting that this study was conducted in a specific population of HIV-infected men with hypogonadism, not the general TRT patient population — but the pharmacokinetic mechanism it describes (a much smaller fluctuation in concentrations with steady-release forms compared to less-frequent injections) is universal and independent of the underlying cause of hypogonadism.

Testosterone is partly converted to estradiol by the enzyme aromatase, and blood estradiol levels change on a rhythm similar to, though not identical with, changes in testosterone — after an injection, estradiol also rises and then falls, with some time lag. Some researchers and clinicians suggest that it's the sharp swings in estradiol concentration, not just testosterone itself, that may partly account for subjectively reported mood swings, since estrogens have their own well-documented influence on the neurotransmitter systems involved in mood regulation.

This is an important, non-obvious practical nuance: in a patient reporting pronounced mood swings on an injectable TRT form, simply reducing the testosterone dose without changing the dosing frequency may not solve the problem, since there will still be a large relative swing amplitude, just at lower absolute values. Changing the dosing frequency or delivery form tends to be a more effective intervention than changing the dose size alone.

It's also worth distinguishing mood swings tied to the dosing rhythm from the question of whether TRT „treats” low mood or depression at all — that's a different, separately studied topic, where the evidence for testosterone therapy's effectiveness as a depression treatment is much more modest than popular belief suggests, and concerns mainly men with confirmed hypogonadism, not the general population with low mood.

Mood swings on TRT are one of those problems easy to misread as a sign that therapy „isn't working” or that the dose needs raising, when the actual fix is often simpler — dosing a smaller amount more often, or switching to a different form of the drug. This distinction is practically useful and worth raising with the prescribing doctor, rather than interpreting every dip in mood as proof of a testosterone shortfall.